These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 1526682)

  • 1. In vitro effect of cefodizime, imipenem/cilastatin and co-trimoxazole on dexamethasone and cyclosporin A depressed phagocytosis.
    Dhondt A; Vanholder R; Waterloos MA; Glorieux G; De Smet R; Ringoir S
    Infection; 1998; 26(2):120-5. PubMed ID: 9561384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulating effects of antibiotics: literature review.
    Van Vlem B; Vanholder R; De Paepe P; Vogelaers D; Ringoir S
    Infection; 1996; 24(4):275-91. PubMed ID: 8875279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in lymphocyte subpopulations in patients treated with cefodizime for acute lower respiratory tract infections.
    Valcke Y; Van der Straeten M
    Infection; 1992; 20 Suppl 1():S58-60. PubMed ID: 1526680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefodizime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Barradell LB; Brogden RN
    Drugs; 1992 Nov; 44(5):800-34. PubMed ID: 1280568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety profile of cefodizime.
    Andrassy K
    Infection; 1992; 20 Suppl 1():S36-40. PubMed ID: 1526675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of effectiveness of cefodizime in the treatment of lower respiratory tract infections with parenchymal involvement.
    Pauwels RA
    Infection; 1992; 20 Suppl 1():S26-30. PubMed ID: 1526672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cefodizime on non-specific immune functions in patients with multiple myeloma.
    Dammacco F; Benvestito S
    Infection; 1992; 20 Suppl 1():S64-6. PubMed ID: 1526682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopharmacological activity of cefodizime in young and elderly subjects: in vitro and ex vivo studies.
    Meroni PL; Capsoni F; Borghi MO; Barcellini W; Minonzio F; Ongari AM; Fain C; Hu C; Brambilla G; Pettenati C
    Infection; 1992; 20 Suppl 1():S61-3. PubMed ID: 1526681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefodizime host-defence enhancement: considerations of dose-response relationships in healthy volunteers.
    Gialdroni Grassi G; Shah PM
    Infection; 1992; 20 Suppl 1():S51-3. PubMed ID: 1526678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cefodizime on chemotaxis and the respiratory burst in neutrophils from diabetics.
    Shaio MF; Chang FY
    J Antimicrob Chemother; 1990 Jul; 26(1):55-9. PubMed ID: 2211447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward a chronoimmunomodulation by cefodizime in multiple myeloma and chronic uremia.
    Carandente F; De Vecchi A; Halberg F; Cornélissen G; Dammacco F
    Chronobiologia; 1988; 15(1-2):61-85. PubMed ID: 3262046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cefodizime on the reagibility of human leukocytes.
    Limbert M; Müllner H; Shah PM
    Infection; 1992; 20 Suppl 1():S48-50. PubMed ID: 1388140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.
    BOYDEN S
    J Exp Med; 1962 Mar; 115(3):453-66. PubMed ID: 13872176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of polyclonal immunoglobulins in multiple myeloma: relationship to the staging and other manifestations at diagnosis.
    Pruzanski W; Gidon MS; Roy A
    Clin Immunol Immunopathol; 1980 Oct; 17(2):280-6. PubMed ID: 7408241
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.